Specialized Medical Company (TADAWUL:4019)
Saudi Arabia
· Delayed Price · Currency is SAR 18.39
+0.08 (0.44%)
Apr 29, 2026, 3:19 PM AST
TADAWUL:4019 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Revenue | 1,538 | 1,438 | 1,368 | 1,209 | 1,053 | Upgrade
|
| Revenue Growth (YoY) | 7.00% | 5.11% | 13.18% | 14.77% | 21.44% | Upgrade
|
| Cost of Revenue | 1,157 | 1,077 | 1,019 | 930 | 824.89 | Upgrade
|
| Gross Profit | 381.59 | 361.06 | 348.96 | 278.66 | 228.24 | Upgrade
|
| Selling, General & Admin | 146.6 | 130.59 | 134.38 | 150.91 | 159.04 | Upgrade
|
| Operating Expenses | 146.6 | 130.59 | 134.38 | 150.91 | 159.04 | Upgrade
|
| Operating Income | 234.99 | 230.47 | 214.58 | 127.75 | 69.2 | Upgrade
|
| Interest Expense | -42.47 | -45.17 | -48.46 | -29.82 | -18.89 | Upgrade
|
| Other Non Operating Income (Expenses) | 19.36 | 8.35 | 8.52 | 9.13 | 8.98 | Upgrade
|
| EBT Excluding Unusual Items | 211.87 | 193.66 | 174.65 | 107.05 | 59.29 | Upgrade
|
| Gain (Loss) on Sale of Assets | 60.63 | - | 0.05 | 0.06 | - | Upgrade
|
| Pretax Income | 272.5 | 193.66 | 174.7 | 107.12 | 59.29 | Upgrade
|
| Income Tax Expense | 6.27 | 8.44 | 6 | 4.15 | 3.32 | Upgrade
|
| Net Income | 266.23 | 185.22 | 168.7 | 102.96 | 55.97 | Upgrade
|
| Net Income to Common | 266.23 | 185.22 | 168.7 | 102.96 | 55.97 | Upgrade
|
| Net Income Growth | 43.74% | 9.79% | 63.84% | 83.97% | 21.62% | Upgrade
|
| Shares Outstanding (Basic) | 250 | 250 | 85 | 85 | 85 | Upgrade
|
| Shares Outstanding (Diluted) | 250 | 250 | 85 | 85 | 85 | Upgrade
|
| Shares Change (YoY) | - | 194.12% | - | - | - | Upgrade
|
| EPS (Basic) | 1.06 | 0.74 | 1.98 | 1.21 | 0.66 | Upgrade
|
| EPS (Diluted) | 1.06 | 0.74 | 1.98 | 1.21 | 0.66 | Upgrade
|
| EPS Growth | 43.74% | -62.67% | 63.84% | 83.97% | 21.62% | Upgrade
|
| Free Cash Flow | 228.28 | 289.52 | 160.53 | 116.6 | -159.38 | Upgrade
|
| Free Cash Flow Per Share | 0.91 | 1.16 | 1.89 | 1.37 | -1.88 | Upgrade
|
| Gross Margin | 24.80% | 25.11% | 25.51% | 23.05% | 21.67% | Upgrade
|
| Operating Margin | 15.27% | 16.03% | 15.69% | 10.57% | 6.57% | Upgrade
|
| Profit Margin | 17.30% | 12.88% | 12.33% | 8.52% | 5.31% | Upgrade
|
| Free Cash Flow Margin | 14.84% | 20.14% | 11.73% | 9.65% | -15.13% | Upgrade
|
| EBITDA | 297.44 | 288.94 | 273.08 | 202.59 | 141.55 | Upgrade
|
| EBITDA Margin | 19.33% | 20.10% | 19.96% | 16.76% | 13.44% | Upgrade
|
| D&A For EBITDA | 62.46 | 58.47 | 58.49 | 74.85 | 72.35 | Upgrade
|
| EBIT | 234.99 | 230.47 | 214.58 | 127.75 | 69.2 | Upgrade
|
| EBIT Margin | 15.27% | 16.03% | 15.69% | 10.57% | 6.57% | Upgrade
|
| Effective Tax Rate | 2.30% | 4.36% | 3.44% | 3.88% | 5.60% | Upgrade
|
| Advertising Expenses | 15.99 | 8.95 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.